EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

New onset refractory status epilepticus ( NORSE ) versus refractory status epilepticus not meeting NORSE criteria: A comparative clinical and electroencephalography‐based study

Seren Hawksworth iD, Nina Moutonnet, Gregory Scott, Sanjeev Rajakulendran, Mahinda Yogarajah iD, Matthew C Walker iD, Umesh Vivekananda iD

Epilepsia · 2026

DOI: 10.1002/epi.70384 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Epilepsia, 2026. Verfasst von Seren Hawksworth und 6 weiteren Autor:innen. Beteiligte Einrichtung: University College London Queen Square Institute of Neurology, London, UK. Hauptthemen laut MEDLINE: Status Epilepticus, Electroencephalography, Drug Resistant Epilepsy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

New onset refractory status epilepticus (NORSE) is a rare, severe presentation of refractory status epilepticus (RSE), with approximately half of cases cryptogenic NORSE (c‐NORSE). We compared electroencephalographic (EEG) findings alongside clinical features between NORSE and RSE not meeting NORSE criteria to better understand outcomes and prognostication.

Methods

This retrospective cohort study analyzed 81 RSE patients admitted to the intensive therapy unit (ITU) at the National Hospital for Neurology and Neurosurgery and University College London Hospital (2007–2023). Patients were categorized as RSE not meeting NORSE criteria ( n = 52) or NORSE ( n = 29). EEG features, treatment, and outcomes (ITU stay, mortality, cognitive outcome, and antiseizure medication [ASM] use), were evaluated.

Results

Of 29 NORSE patients (15 c‐NORSE, 51.7%; 14 etiology‐identified NORSE, 48.3%), autoimmune (20.7%) and infectious (17.2%) etiologies were most prevalent. Six‐month mortality was higher in c‐NORSE than etiology‐identified NORSE (20.0% vs. 7.1%), but similar between NORSE and RSE not meeting NORSE criteria (13.8% vs. 21.1%). EEG analysis revealed longer seizure duration (mean = 243.38 vs. 51.67 s, p < .001), a tendency to higher seizure frequency (.013 vs. .009 seizures/min, p = .076), and increased presence of generalized periodic epileptiform discharges and stimulus‐induced rhythmic, periodic, or ictal discharges in NORSE than RSE not meeting NORSE criteria. Across all patients, higher initial seizure burden correlated with longer ITU admissions and worse outcomes. Compared with RSE not meeting NORSE criteria, NORSE patients had longer ITU stays (median = 51 vs. 11 days, p < .001), more ASMs (mean = 3.91 vs. 2.00, p = .031), greater sedative use (mean = 2.17 vs. 1.00, p < .001), and more frequent cognitive impairment at discharge (88.9% vs. 62.2%, p = .037). Significance NORSE, particularly c‐NORSE, tends to follow a more severe course than RSE not meeting NORSE criteria, with more severe background EEG features including the initial EEG, greater seizure burden, longer ITU stays, and increased incidence of cognitive impairment at discharge. Six‐month mortality was similar, implying additional contributing factors to mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Status EpilepticusElectroencephalographyDrug Resistant EpilepsyHumansFemaleMaleRetrospective StudiesMiddle AgedAdultAgedPrognosisAnticonvulsants

Stichwörter der Autor:innen

ElectroencephalographyNew‐onset refractory status epilepticusRefractory status epilepticusStatus EpilepticusSuper‐refractory status epilepticus

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • University College London Queen Square Institute of Neurology, London, UK.
  • Imperial College London, UK Dementia Research Institute, London, UK.
  • Imperial College London, London, UK.

ORCID-Profile: Seren Hawksworth, Mahinda Yogarajah, Matthew C Walker, Umesh Vivekananda

Förderung

  • Wellcome Trust

Zitieren

APA

Hawksworth, S., Moutonnet, N., Scott, G., Rajakulendran, S., Yogarajah, M., Walker, M. C., & Vivekananda, U. (2026). New onset refractory status epilepticus ( NORSE ) versus refractory status epilepticus not meeting NORSE criteria: A comparative clinical and electroencephalography‐based study. Epilepsia. https://doi.org/10.1002/epi.70384

Vancouver

Hawksworth S, Moutonnet N, Scott G, Rajakulendran S, Yogarajah M, Walker MC, et al. New onset refractory status epilepticus ( NORSE ) versus refractory status epilepticus not meeting NORSE criteria: A comparative clinical and electroencephalography‐based study. Epilepsia. 2026. doi:10.1002/epi.70384

BibTeX
@article{Hawksworth2026,
  author = {Hawksworth, Seren and Moutonnet, Nina and Scott, Gregory and Rajakulendran, Sanjeev and Yogarajah, Mahinda and Walker, Matthew C and Vivekananda, Umesh},
  title = {New onset refractory status epilepticus ( NORSE ) versus refractory status epilepticus not meeting NORSE criteria: A comparative clinical and electroencephalography‐based study},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70384}
}
Kostenlos starten →